Conversion From Immediate Release Tacrolimus to Envarsus XR® in Simultaneous Pancreas-Kidney Recipients: Assessment of Functional, Safety and Quality of Life Outcomes (CIRTEN SPK)
Phase of Trial: Phase II/III
Latest Information Update: 12 Feb 2019
At a glance
- Drugs Tacrolimus (Primary)
- Indications Kidney-pancreas transplant rejection
- Focus Adverse reactions
- Acronyms CIRTEN SPK
- 08 Feb 2019 Planned initiation date changed from 1 Feb 2019 to 15 Feb 2019.
- 01 Feb 2019 Planned initiation date changed from 21 Jan 2019 to 1 Feb 2019.
- 01 Feb 2019 Status changed from not yet recruiting to recruiting.